Novo Nordisk Offers New Contender in Weight Management US$ 26.12 Min. order: 1 piece ★★★★★ 4.9 (159 reviews) Sold : Login>>
Novo Nordisk presents phase 3 data for next-generation amylin cagrilintide, leading to advancement into dedicated clinical programme US$ 27.05 Min. order: 1 piece ★★★★★ 4.2 (184 reviews) Sold : Login>>
Novo Nordisk's CagriSema trial deals blow in obesity drug battle with Eli Lilly US$ 21.95 Min. order: 1 piece ★★★★★ 5.0 (93 reviews) Sold : Login>>
New semaglutide and cagrilintide/semaglutide results US$ 23.95 Min. order: 1 piece ★★★★★ 4.9 (215 reviews) Sold : Login>>
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity US$ 20.11 Min. order: 1 piece ★★★★★ 5.0 (127 reviews) Sold : Login>>